fungi
parasit
caus
cnsi
test
panel
assay
includ
microorgan
speci
across
genera
famili
analyt
specif
sensit
examin
use
panel
posit
refer
strain
clinic
perform
evalu
use
clinic
sampl
compar
result
qpcr
assay
result
demonstr
good
perform
assay
term
sensit
specif
detect
rang
suggest
platform
develop
highthroughput
cnsi
diagnosi
abstract
central
nervou
system
infect
cnsi
result
signific
health
econom
burden
worldwid
divers
caus
pathogen
make
differenti
diagnosi
difficult
although
pcr
realtim
fluoresc
quantit
pcr
qpcr
assay
wide
appli
pathogen
detect
gener
optim
detect
singl
limit
number
target
suitabl
diagnosi
numer
cnsi
agent
studi
describ
develop
resequenc
pathogen
microarray
method
simultan
detect
virus
bacteria
handl
editor
martin
schwemml
onlin
version
articl
central
nervou
system
infect
cnsi
result
signific
health
econom
burden
worldwid
divers
pathogen
make
differenti
diagnosi
difficult
enceph
mening
seriou
diseas
cn
howev
etiolog
remain
unknown
case
infecti
caus
describ
difficult
provid
consensu
clinic
biolog
definit
syndrom
even
difficult
relat
enceph
mening
specif
agent
cnsi
agent
found
across
viral
bacteri
fungal
parasit
taxonom
group
clear
major
asept
mening
case
caus
enteroviru
ev
speci
mostli
target
children
develop
countri
common
import
caus
viral
enceph
human
herpesvirus
hhv
includ
herp
simplex
virus
varicellazost
viru
vzv
epsteinbarr
viru
ebv
cytomegaloviru
cmv
human
herp
viru
case
due
japanes
enceph
viru
jev
like
caus
enceph
children
adult
wherea
elderli
suscept
west
nile
viru
wnv
infect
subacut
sclerosingpanenceph
result
persist
measl
viru
mev
infect
progress
panenceph
may
occur
mani
year
congenit
perinat
rubella
viru
ruv
infect
neisseria
meningitidi
haemophilusinfluenza
streptococcu
pneumonia
lead
caus
bacteri
mening
mani
microorgan
includ
fungi
parasit
relat
cnsi
far
less
common
tradit
method
identif
cnsi
agent
base
cultur
although
reliabl
familiar
seri
drawback
pathogen
cultur
time
consum
signific
proport
microorgan
amen
cultur
moreov
facil
need
assur
safeti
contain
highrisk
agent
molecular
method
pcr
realtim
fluoresc
quantit
pcr
qpcr
may
provid
rapid
identif
base
nucleic
acid
amplif
techniqu
naat
compar
culturebas
assay
naat
rapid
sensit
appropri
identif
noncultur
pathogen
serotyp
howev
pcrqpcr
method
use
optim
detect
singl
limit
number
target
although
sensit
specif
appropri
detect
multipl
vari
pathogen
cnsi
agent
numer
therefor
highli
desir
develop
method
achiev
simultan
detect
multipl
agent
caus
similar
clinic
syndrom
andor
share
similar
epidemiolog
featur
enceph
mening
resequenc
pathogen
microarray
rpm
promis
technolog
allow
simultan
detect
mani
infecti
agent
thousand
synthes
oligonucleotid
probe
coval
fixat
glassor
siliconbas
highdens
microarray
nucleic
acid
amplifi
use
specif
pcr
follow
purif
fragment
label
label
sampl
inject
rpm
hybrid
overnight
hybrid
oven
short
fluorophor
label
dna
fragment
bp
deriv
sampl
hybrid
probe
wash
stain
fluidic
station
microarray
scan
calcul
fluoresc
signal
valu
pathogenspecif
sequenc
inform
produc
fastaformat
output
file
sequenc
inform
produc
rpm
allow
highresolut
pathogen
identif
nearneighbor
discrimin
make
rpm
suitabl
outbreak
investig
caus
atyp
uncommon
pathogen
sever
rpm
assay
develop
diagnost
platform
effect
simultan
detect
larg
number
divers
clinic
environment
pathogen
rpm
assay
report
identif
cnsi
pathogen
studi
describ
develop
rpm
method
simultan
detect
cnsi
agent
includ
virus
bacteria
fungi
parasit
detect
panel
list
tabl
consist
microorgan
speci
genera
famili
analyt
specif
sensit
examin
clinic
perform
assay
evalu
compar
result
relat
qpcr
assay
januari
decemb
clinic
cerebrospin
fluid
csf
sampl
collect
patient
diagnos
acut
viral
mening
enceph
base
clinic
symptom
clinic
diagnosi
csf
sampl
conduct
beij
children
hospit
children
hospit
hebei
provinc
hospit
shijiazhuang
second
hospit
hebei
medic
univers
aspect
studi
perform
accord
nation
ethic
regul
approv
institut
review
board
chines
center
diseas
control
prevent
china
cdc
hospit
patient
children
parent
appris
studi
purpos
right
keep
inform
confidenti
written
consent
obtain
patient
children
parent
total
nucleic
acid
extract
csf
use
masterpur
complet
dna
rna
purif
kit
epicent
technolog
madison
wi
accord
manufactur
instruct
purifi
dna
rna
store
total
pair
genespecif
primer
design
institut
viral
diseas
control
prevent
ivdc
tessara
llc
detail
sequenc
inform
primer
probe
present
supplementari
materi
pathogen
primer
probe
design
accord
criteria
describ
previous
brief
uniqu
primer
check
use
full
search
genbank
databas
blast
program
minim
possibl
primer
dimer
help
ensur
suffici
amplif
six
independ
multiplex
primer
cocktailspool
develop
amplif
target
sequenc
repres
microarray
six
multiplex
primer
cocktail
shown
figur
mix
dedic
primarili
bunyavirus
paramyxovirus
rhabdovirus
mix
ii
flavivirus
mix
iii
picornavirus
retrovirus
mix
iv
arenavirus
togavirus
retrovirus
herpesvirus
mix
v
viral
taxonom
inform
retriev
intern
committe
taxonomi
virus
ictv
databas
bacteri
fungal
parasit
taxonom
inform
retriev
ncbi
taxonomi
databas
total
pair
speciesgenu
specif
primer
design
base
genom
pathogen
tabl
detail
sequenc
inform
present
supplementari
materi
work
flow
total
nucleic
acid
extract
csf
sampl
rna
transcrib
cdna
six
independ
primer
cocktailspool
use
multiplex
pcr
product
pool
togeth
subject
purif
purifi
pcr
product
fragment
min
label
min
microarray
hybrid
process
carri
accord
manufactur
recommend
protocol
raw
imag
file
obtain
scan
microarray
convert
fasta
file
use
tessarray
sequenc
analysi
tseq
softwar
data
analyz
use
bioinformat
cloud
server
final
diagnost
report
sent
back
rpm
oper
bacteria
mix
vi
fungi
parasit
strategi
temperatur
switch
pcr
tsp
appli
rpm
assay
one
pair
univers
primer
adapt
previou
studi
chimer
primer
consist
genespecif
sequenc
fuse
univers
tag
sequenc
thu
chimer
primer
similar
anneal
temperatur
assur
approxim
amplif
effici
two
arabidopsi
thaliana
gene
tim
select
intern
neg
control
plant
gene
would
unlik
occur
natur
clinic
sampl
revers
transcript
use
superscript
iii
invitrogen
lifetechnolog
carlsbad
ca
perform
use
random
hexam
total
volum
six
target
multiplex
pcr
assay
primer
mix
vi
product
six
multiplex
pcr
tube
pool
togeth
subject
purif
qiagen
purifi
pcr
product
fragment
min
label
min
microarray
hybrid
process
carri
accord
manufactur
recommend
protocol
affymetrix
inc
santa
clara
ca
use
genechip
resequenc
assay
kit
affymetrix
inc
raw
imag
file
obtain
scan
microarray
convert
fasta
file
use
tessarray
sequenc
analysi
tseq
softwar
fasta
output
file
subject
align
correspond
detector
tile
sequenc
prototyp
sequenc
repres
portion
genom
dnarna
target
organ
qualiti
sequenc
evalu
score
total
number
tseqidentifi
nucleotid
appear
run
three
consecut
nonn
base
call
express
percentag
length
nucleotid
detector
tile
sequenc
data
analyz
use
bioinformat
cloud
server
final
diagnost
report
sent
back
rpm
oper
primer
specif
rpm
test
previous
confirm
posit
cnsi
sampl
among
viralposit
bacterialposit
remain
pathogen
posit
sampl
unavail
artifici
synthes
target
dna
genom
sequenc
thu
primer
probe
rpm
test
subset
sampl
posit
sampl
select
evalu
limit
detect
lod
rpm
assay
quantit
recombin
plasmid
dna
virus
bacteria
vitro
transcrib
rna
rna
virus
prepar
previous
describ
tenfold
serial
dilut
rnadna
templat
known
copi
number
use
evalu
lod
rpm
assay
total
sampl
test
simultan
rpm
assay
qpcr
primer
probe
adopt
report
qpcr
method
detect
ev
hsv
vzv
ebv
cmv
hhv
statist
analys
perform
use
statist
packag
social
scienc
softwar
test
mcnemar
test
conduct
measur
sensit
specif
detect
agreement
rpm
qpcr
assay
rpm
assay
could
discrimin
identifi
refer
strain
list
tabl
except
rhinoviru
rv
artifici
synthes
dna
repres
unavail
posit
sampl
mix
togeth
test
use
rpm
crossreact
observ
analyt
sensit
rpm
assay
evalu
use
serial
dilut
vitro
transcrib
rna
dna
clone
lod
rang
copiesreact
monosampl
copiesreact
mixedsampl
tabl
result
obtain
clinic
csf
sampl
figur
posit
result
determin
case
use
rpm
includ
posit
ev
posit
total
jev
cmv
ebv
muv
mix
infect
seven
case
includ
ev
jev
ev
ebv
thu
among
mix
infect
ev
jev
ebv
infect
identifi
case
found
hiv
mev
tbev
ruv
wnv
jcv
vzv
adv
infect
vzv
cmv
detect
result
coincid
obtain
parallel
qpcr
assay
ev
ebv
rpm
detect
sensit
rpm
assay
detect
five
case
ev
infect
one
ebv
one
qpcr
tabl
addit
rpm
assay
detect
case
jev
infect
one
muv
infect
includ
qpcr
panel
aforement
case
detect
qpcr
true
posit
confirm
monoplex
pcr
follow
sanger
sequenc
rpm
platform
proven
success
identif
character
numer
clinic
pathogen
includ
avian
influenza
rhinovirus
enterovirus
arbovir
viru
well
pathogen
environment
sampl
studi
develop
evalu
identif
viral
bacteri
fungal
parasit
pathogen
known
caus
relat
cnsi
studi
demonstr
platform
achiev
highlysensit
specif
detect
multipl
cn
diseas
agent
singl
test
properli
design
multiplex
pcr
strategi
essenti
improv
perform
rpm
hybrid
process
alreadi
standard
specif
test
use
known
posit
sampl
demonstr
capabl
discrimin
among
differ
cnsi
pathogen
primer
tile
ev
design
accord
region
utr
rpm
could
discrimin
rv
ev
situat
qpcr
assay
studi
use
tsp
technolog
maintain
target
enrich
mitig
amplif
bia
among
differ
primer
pair
lod
experi
show
could
detect
littl
copiesreact
target
gene
compar
report
method
meet
diagnost
requir
describ
design
detect
broad
rang
pathogen
tabl
singl
specimen
thu
addit
common
cnsi
agent
method
also
allow
detect
lowpreval
emerg
infecti
agent
exampl
arenavirus
bunyavirus
anaplasmatacea
mycoplasma
rickettsia
commonli
present
csf
univers
distribut
includ
panel
addit
design
amplifi
sever
differ
gene
target
one
microorgan
improv
detect
rate
multipl
primer
pair
tile
per
pathogen
sequenc
two
separ
region
one
pathogen
amplifi
hybrid
exampl
region
detect
simultan
use
specif
primer
identif
wnv
mani
nine
gene
target
includ
aro
gyrb
meca
lukpv
etoxa
etoxb
etoxc
alphatox
tstox
tile
microarray
detect
identifi
staphylococcu
aureu
compar
qpcr
convent
method
main
advantag
enabl
comprehens
detect
cnsi
pathogen
shown
tabl
almost
common
cnsi
pathogen
includ
test
menu
atypicaluncommon
cnsi
pathogen
could
also
detect
method
amplifi
highlyconserv
sequenc
use
multipl
primer
greater
number
posit
case
could
detect
rpm
qpcr
exampl
variat
suffici
allow
accur
identif
group
ev
design
primer
pair
specif
region
shown
tabl
rpm
report
five
evposit
case
equival
qpcr
assay
although
method
target
ev
detect
set
primer
pair
probe
rpm
undoubtedli
provid
greater
probabl
oligonucleotid
match
one
set
use
refer
qpcr
result
higher
clinic
sensit
rpm
similarli
one
ebv
one
mistakenli
defin
case
unclear
etiolog
qpcr
could
success
identifi
rpm
thu
conclud
rpm
array
maxim
likelihood
hybrid
primer
conserv
region
within
given
viral
genusfamili
demonstr
effect
strategi
detect
highlyvari
uncharacter
virus
addit
multipl
gener
sequenc
inform
concern
pathogen
variat
achiev
greater
discrimin
among
subtyp
none
avail
commerci
assay
provid
pathogenspecif
sequenc
inform
characterist
make
rpm
power
identif
tool
also
allow
pathogen
phylogenet
categor
base
genet
variat
assay
laboratori
establish
sever
microorgan
identif
method
use
roch
illumina
ion
torrent
platform
compar
throughput
multipl
complex
timecost
reagentcost
laborcost
rpm
nextgener
sequenc
ng
perform
similar
clinic
studi
found
rpm
conveni
suffici
meet
need
pathogen
identif
although
librari
construct
sequenc
process
ng
becom
easier
reagent
kit
commerci
avail
bioinformat
analysi
remain
complex
timeconsum
hurdl
requir
high
level
expertis
contrast
primer
probe
rpm
predetermin
relat
critic
region
sequenc
target
pathogen
thu
requir
littl
bioinformat
expertis
among
oper
clinic
sampl
test
present
studi
posit
sampl
account
pathogen
detect
sampl
indic
test
csf
alon
sensit
enough
cnsi
diagnosi
maxim
detect
rate
cnsi
agent
recommend
naat
antibodi
studi
use
togeth
csf
test
gener
allow
definit
result
test
sampl
type
blood
throat
swab
fece
skin
biopsi
may
also
provid
addit
diagnost
inform
caus
agent
testneg
clinic
sampl
might
repres
known
variant
microorgan
previous
associ
cnsi
inde
complet
unknown
pathogen
failur
detect
might
also
attribut
limit
sensit
specif
current
use
method
suboptim
sampl
collect
time
case
pcrbase
method
disadvantag
rpm
prerequir
knowledg
microorgan
genom
sequenc
overcom
disadvantag
rpm
ng
could
use
identifi
potenti
caus
agent
testneg
sampl
unbias
sequenc
enabl
identif
pathogen
singl
run
current
assay
show
good
perform
term
sensit
specif
detect
rang
suggest
platform
develop
highthroughput
cnsi
diagnosi
howev
autom
must
consid
optim
rpm
design
process
current
format
assay
sampl
finish
within
h
combin
manual
autom
process
decreas
assay
time
reduc
handson
user
error
rpm
adapt
fullautom
difficulti
lie
tradeoff
autom
risk
nucleic
acid
contamin
author
contribut
xuejun
suzhen
sun
ji
wang
design
studi
ji
wang
panhui
yu
tengfei
yan
perform
rpm
experi
chen
chen
xinxin
shen
prepar
sampl
labwar
xiangpeng
chen
zhengdexi
analyz
data
lixin
li
xiuxia
wang
zhengdexi
suzhen
sun
collect
sampl
perform
qpcr
ji
wang
wrote
manuscript
first
three
author
author
list
contribut
equal
research
conflict
interest
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
